BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 24010824)

  • 1. DMOG ameliorates IFN-γ-induced intestinal barrier dysfunction by suppressing PHD2-dependent HIF-1α degradation.
    Wang WS; Liang HY; Cai YJ; Yang H
    J Interferon Cytokine Res; 2014 Jan; 34(1):60-9. PubMed ID: 24010824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediary metabolite precursor dimethyl-2-ketoglutarate stabilizes hypoxia-inducible factor-1α by inhibiting prolyl-4-hydroxylase PHD2.
    Hou P; Kuo CY; Cheng CT; Liou JP; Ann DK; Chen Q
    PLoS One; 2014; 9(11):e113865. PubMed ID: 25420025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
    Lim CS; Kiriakidis S; Paleolog EM; Davies AH
    J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction.
    Liu H; Li M; Wang P; Wang F
    Cytokine; 2011 Dec; 56(3):581-8. PubMed ID: 21890376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway.
    Yang S; Yu M; Sun L; Xiao W; Yang X; Sun L; Zhang C; Ma Y; Yang H; Liu Y; Lu D; Teitelbaum DH; Yang H
    J Interferon Cytokine Res; 2014 Mar; 34(3):195-203. PubMed ID: 24237301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxylase inhibition abrogates TNF-alpha-induced intestinal epithelial damage by hypoxia-inducible factor-1-dependent repression of FADD.
    Hindryckx P; De Vos M; Jacques P; Ferdinande L; Peeters H; Olievier K; Bogaert S; Brinkman B; Vandenabeele P; Elewaut D; Laukens D
    J Immunol; 2010 Nov; 185(10):6306-16. PubMed ID: 20943999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of prolyl hydroxylase domain-containing protein suppressed lipopolysaccharide-induced TNF-alpha expression.
    Takeda K; Ichiki T; Narabayashi E; Inanaga K; Miyazaki R; Hashimoto T; Matsuura H; Ikeda J; Miyata T; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2132-7. PubMed ID: 19762779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolyl-hydroxylase inhibition and chronic intermittent hypoxia on synaptic transmission and plasticity in the rat CA1 and dentate gyrus.
    Wall AM; Corcoran AE; O'Halloran KD; O'Connor JJ
    Neurobiol Dis; 2014 Feb; 62():8-17. PubMed ID: 24055213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The stabilization of hypoxia inducible factor modulates differentiation status and inhibits the proliferation of mouse embryonic stem cells.
    Binó L; Kučera J; Štefková K; Švihálková Šindlerová L; Lánová M; Kudová J; Kubala L; Pacherník J
    Chem Biol Interact; 2016 Jan; 244():204-14. PubMed ID: 26723917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-γ and TNF-α.
    Liu H; Wang P; Cao M; Li M; Wang F
    Cell Physiol Biochem; 2012; 29(5-6):799-808. PubMed ID: 22613980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gambogic acid inhibits angiogenesis through inhibiting PHD2-VHL-HIF-1α pathway.
    Lu N; Hui H; Yang H; Zhao K; Chen Y; You QD; Guo QL
    Eur J Pharm Sci; 2013 May; 49(2):220-6. PubMed ID: 23501055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sestrin2 inhibits hypoxia-inducible factor-1α accumulation via AMPK-mediated prolyl hydroxylase regulation.
    Seo K; Seo S; Ki SH; Shin SM
    Free Radic Biol Med; 2016 Dec; 101():511-523. PubMed ID: 27840318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl hydroxylase domain 2 deficiency promotes skeletal muscle fiber-type transition via a calcineurin/NFATc1-dependent pathway.
    Shin J; Nunomiya A; Kitajima Y; Dan T; Miyata T; Nagatomi R
    Skelet Muscle; 2016; 6():5. PubMed ID: 26949511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 90 and prolyl hydroxylase 2 co-regulate hypoxia-inducible factor-1α expression in porcine small intestinal epithelial cells under heat stress.
    Liu Y; Fan G; Zhang G; Xiong Y; Li H
    J Therm Biol; 2024 May; 122():103881. PubMed ID: 38870755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors induce autophagy and have a protective effect in an in-vitro ischaemia model.
    Singh A; Wilson JW; Schofield CJ; Chen R
    Sci Rep; 2020 Jan; 10(1):1597. PubMed ID: 32005890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of hypoxia-inducible factor-1α exacerbates endothelial barrier dysfunction induced by hypoxia.
    Wang P; Qi H; Sun C; He W; Chen G; Li L; Wang F
    Cell Physiol Biochem; 2013; 32(4):859-70. PubMed ID: 24081113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of IFN-γ and TNF-α-induced intestinal epithelial barrier dysfunction by berberine via suppression of MLCK-MLC phosphorylation signaling pathway.
    Cao M; Wang P; Sun C; He W; Wang F
    PLoS One; 2013; 8(5):e61944. PubMed ID: 23671580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of hypoxia and LPS-induced intestinal epithelial barrier dysfunction by emodin through the suppression of the NF-κB and HIF-1α signaling pathways.
    Lei Q; Qiang F; Chao D; Di W; Guoqian Z; Bo Y; Lina Y
    Int J Mol Med; 2014 Dec; 34(6):1629-39. PubMed ID: 25318952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src activates HIF-1α not through direct phosphorylation of HIF-1α specific prolyl-4 hydroxylase 2 but through activation of the NADPH oxidase/Rac pathway.
    Lee HY; Lee T; Lee N; Yang EG; Lee C; Lee J; Moon EY; Ha J; Park H
    Carcinogenesis; 2011 May; 32(5):703-12. PubMed ID: 21335603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for the regulation of hypoxia-inducible factor-1α levels by 2-deoxy-D-ribose.
    Ikeda R; Tabata S; Tajitsu Y; Nishizawa Y; Minami K; Furukawa T; Yamamoto M; Shinsato Y; Akiyama S; Yamada K; Takeda Y
    Oncol Rep; 2013 Sep; 30(3):1444-8. PubMed ID: 23807085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.